15th European Molecular Imaging Meeting
supported by:

To search for a specific ID please enter the hash sign followed by the ID number (e.g. #123).
Keyword Contributions
13c-mrs PS 18-04
177lu-dota-lm3 PS 07-04
18f-dpa-714 PS 19-03
18f-fdg pet/ct PS 22-04
18f-labeling PS 06-02
18f-naf pet PS 23-03PS 17-03
18f-naf pet/ct PS 09-02
18f0fluoroestradiol PS 18-05
19f PS 21-02
19f mri PS 16-02PS 05-04PS 05-04102
19f mrs PS 21-02
19f press PS 05-04
19f-cest mri PS 23-01
19f-mri PS 23-01PS 04-06
22rv1 PS 19-02PS 17-05
31p-mr 102
3d cell culture PS 13-01
3d deep imaging 105
3d electron microscopy PS 23-05
3d fluorescence imaging PS 22-03
3d imaging PS 15-03PS 04-05
3d in-vitro co-culture PS 18-03
3d microct 106
3d t1 mapping PS 10-04
3d uct/blt PS 10-03
4d strain analysis PS 23-03
4d ultrasound PS 23-03
4t1 PS 06-03
68ga PS 06-02
68ga-nodaga-lm3 PS 07-04
800cw-tate 105
89zr PS 07-04PS 10-03
89zr-immuno-pet PS 18-04PS 23-02
[11c]methylreboxetine PS 18-06
[11c]pib PS 19-03
[18f]dpa-714 PS 04-05PS 10-02
[18f]fdg PS 22-03PS 23-04
[18f]fmiso PS 21-02
[18f]jhu94620 PS 19-03
[18f]thk-5317 PS 19-03
abdominal aortic aneurysms PS 05-04
ac-225 #293
accurate measurement PS 22-03
ace PS 05-04
ace2 PS 05-04
acidic extracellular ph PS 13-01PS 18-02
acoustic inverse problem PS 22-03
adc PS 21-02
adrenal involvement PS 22-04
aducanumab PS 23-02
adult zebrafish PS 04-04
aging PS 23-03PS 17-03
ai algorithm PS 08-04
al18f-labelling PS 22-05
ala photodynamic theraphy PS 18-04
alcohol abuse PS 18-06
alginate 102
alk PS 18-05
alpha synuclein #437
alpha-synuclein PS 15-05PS 19-03
alzheimer's disease PS 08-04PS 10-02PS 19-03PS 22-03
alzheimer’s disease PS 19-03
alzheimer’s disease model PS 23-04
amyloid beta PS 05-03
amyloid-beta PS 23-02PS 23-02
anesthesia PS 18-06
aneurysm PS 23-03100
angiogenesis 100
angiography PS 05-05
animal model PS 19-03PS 19-03PS 21-06PS 23-04PS 23-03PS 17-03
animal models PS 11-01PS 08-04
anisotropy PS 05-05
anorexia nervosa PS 18-06
anti-pd1 #293
antibody PS 23-02
antibody fragments PS 01-02
antibody-radioconjugate PS 10-05PS 18-01
antifungal screening 100
aortic dissections PS 05-04
aortitis 100
apparent diffusion coefficient PS 04-05
application routes PS 05-02
aqp4 PS 10-02
arterial input function PS 10-04
arterial switch operation PS 23-02
artificial intelligence PS 04-01PS 04-01
ascites PS 18-02
aspergillus fumigatus 100
astatine-211 PS 19-02
astrocytes PS 19-03
atherosclerosis #322PS 23-03PS 17-03
atp fret sensor PS 23-05
atri PS 19-02
attention u-net PS 22-03
au nanoparticles PS 22-05
au nps 101
auditory pathway PS 23-05
auditory stimulated fmri PS 23-05
augmented reality PS 21-04
autofluorescence 105
automatic cell segmentation PS 15-05
automation PS 21-05
autoradiography PS 22-06
awake imaging PS 04-04
axonal mitochondria PS 23-05
axr PS 21-02PS 21-02
aza-bodipy PS 04-06
b1 map PS 21-02
backscatter tensor imaging PS 05-05
barrett's esophagus PS 05-02
barrett's esophagus neoplasia PS 05-02
bevacizumab-800cw PS 05-02
bifunctional chelator PS 21-05
bifunctional chelators PS 21-05
bimodal imaging 104104
bimodal probe PS 04-06
bimodal tracer PS 18-05
biochemical markers of bone turnover PS 09-02
biocompatibility PS 09-04
bioconjugates PS 21-05
bioconjugation PS 21-05#363
biodegradable metal implants PS 21-06
biodegradable polymers 102
biodistribution PS 21-04
bioengineering PS 18-05
biohybrid tissue-engineered vascular graft PS 23-03
bioimaging PS 04-06
bioliminiscence PS 22-04
bioluminescence PS 15-05
bioluminescence imaging PS 05-04100120
bioluminescence imaging (bli) PS 05-05
biomarker PL 07-09-02PS 15-03PS 23-01PS 18-02PS 23-04
biomarker discovery PS 17-01
biomarkers PS 10-03PS 19-03
biomaterials PS 13-01
biomedical engineering PS 18-06
bioorthogonal chemistry PS 08-02
bioreactor PS 21-02
biosensor PS 18-02
biosensors PS 10-06
bisfluorinated PS 21-02
bladder 102
blind source separation PS 08-04
blood brain barrier PS 23-02
blood flow PS 21-02
blood halflife PS 21-02
blood pool agents 102
bnct PS 04-06
bodipy PS 04-06104
body-conforming animal mold 120
bone 102
bone microenvironment PS 10-05PS 18-01
boron neutron capture therapy. 101PS 17-05
brachial plexus injury PS 23-05
bradykinin receptor type 2 PS 23-04
brain #551PS 08-04PS 18-06PS 23-04PS 23-04
brain plasticity PS 23-05
brain activation PS 05-03
brain imaging PS 23-01PS 05-05PS 09-03
brain ischemia PS 23-04
brain ischemia-reperfusion PS 10-02
brain region segmentation PS 22-03
brain uptake PS 23-02
brain-heart interaction PS 23-03
breast cancer PS 18-05PS 18-05PS 21-04PS 21-06PS 21-06PS 22-03PS 22-05PS 17-04
brigatinib PS 18-05
bssfp PS 18-04
c9orf72 PS 15-05
caa PS 23-02
caffeine PS 19-03
calcification PS 23-03PS 17-03
calcium deposit PS 22-03
calcium influx PS 13-01PS 18-02
calcium quantification PS 22-03
calcium recording PS 05-03
cancer PS 13-01PS 04-04PS 06-03PS 19-02100101
cancer cell membranes 120
cancer cell targeting PS 18-04
cancer diagnosis PS 06-03
cancer imaging PS 18-05
cancer immunotherapy #572PS 13-01PS 10-05
cancer progression PS 18-02
cancer therapy PS 08-02
car t cell PS 18-03
car t cells PS 10-03PS 18-04
car t-cell therapy PS 22-06
carbon dioxide PS 23-03
carbon-13 PS 21-02
carbon-based nanomaterials PS 18-06
carcinoma PS 08-02
cardiac #501
cardiac gating PS 23-03
cardiac maturation PS 23-03PS 17-03
cardiac progenitor cells #433
cardiac sarcoidosis #518
cardiac tissue #338
cardio imaging PS 23-03
cardiomyoyte PS 10-06
cardiovascular disease PS 16-02
cardiovascular imaging #322
cb2 PS 19-03
cd4+ t cells 100PS 18-01
cd8 t cell 100
cell culture 100
cell encapsulation 102
cell labelling PS 06-02PS 18-05PS 18-05
cell mechanics PS 15-03
cell nucleus PS 08-04
cell therapy PS 04-04PS 10-03
cell tracking PS 05-04#433#322PS 06-02PS 06-02PS 08-03PS 10-03PS 10-03PS 10-03PS 21-02PS 22-06100100104PS 18-01
cell-penetrating peptides PS 18-05
cellular imaging PS 13-05
cellular interactions PS 18-03
central reorganization PS 23-05
cerebral blood flow PS 23-05
cerebrovascular #551
cerenkov PS 04-04
cest PS 02-01PS 14-02PS 04-05PS 21-06
cest mri PS 23-01PS 04-05PS 06-03
cetuximab-800cw PS 07-04PS 21-04PS 21-04
chemogenetic biosensors PS 10-06
chemogenetic reporters PS 21-03
chemogenetic systems PS 09-04
chitosan 102
chk1 PS 21-05
cholinergic neuromodulation PS 18-06PS 19-01
chondrosarcoma PS 04-05
chronic liver diseases 100
circulating cell-free dna PS 22-05
classical and quasi-mesenchymal (qm) subtypes PS 09-02
classification PS 23-04
clearing agent PS 05-03
clem PS 08-01
clinical feasible protocol PS 21-02
clinical translation PS 15-05PS 10-03
clinical trial PS 05-02
clonal dynamics PS 04-05
cmr PS 21-06
cnn PS 23-02100
cns-disorder PS 23-05
co-activation patterns PS 23-04
coarctation of the aorta PS 21-02
cochlea 106
colon carcinoma PS 18-03
colorants 120
computational modelling PS 01-01
computed tomography PS 01-01#338PS 22-03
computer-assisted intervention PS 21-04
connectivity PS 05-03PS 10-06PS 19-01
connectivity imaging #551
contrast agent PS 23-03#533106
contrast agent kinetics PS 05-05
contrast agents PS 18-04
contrast imaging PS 23-03
convolution neural network PS 04-01
copd PS 04-03
core-shell PS 06-02104
correlative imaging PS 08-01106
correlative microscopy PS 08-03
covid-19 #338PS 06-02
covid19 PS 15-03
crohn's disease PS 07-04
cryo-electron tomography PS 15-05
cryptococcosis PS 23-04
csf-1r PS 04-05PS 10-02
ct PS 04-01PS 10-06PS 22-05
curcumin PS 09-03
current density imaging PS 10-04
custom setup 106
cutaneous squamous cell carcinoma PS 21-04
cutaneous t cell lymphoma PS 10-05
cxcr4 imaging PS 22-05
cyanine dyes PS 21-03
cyclen PS 21-05
cyclic immunofluorescence PS 10-03
cysts 106
cytoskeleton PS 09-04
d-peptide-based probe PS 22-05
da vinci surgical robot PS 22-03
data analysis 120
data integration PS 17-01
dce-mri PS 10-02
deep learning-based cell segmentation PS 15-03
deep-tissue imaging PS 21-03
deformability cytometry PS 15-03
degradable materials PS 22-05
deisotoping 105
delayed-type hypersensitivity reactions 100PS 18-01
denoising PS 22-03
depth sensing 120
desferrioxamine #363
design of experiments PS 04-01
deuterium spectroscopy PS 09-02
developmental maturation PS 23-05
diabetes mellitus PS 23-04
diagnosis 100
dielectric nanoparticles PS 08-03
diffusion PS 23-04
diffusion mri PS 07-05PS 18-06PS 18-06
diffusion weighted imaging PS 18-05
diffusion weighted-magnetic resonance imaging PS 04-05
direct labeling PS 22-06
dissolution of nanoparticles PS 21-03
dki PS 18-06
dmi PS 21-06
doe PS 04-01
dosimetry PS 22-06
down syndrome development PS 23-03
doxorubicin 101
dreadds PS 18-06PS 19-01
drug delivery 101101101PS 17-05
dstorm PS 08-04
dti PS 18-06
dual color in vivo imaging PS 10-05
dual energy ct PS 17-03
dual-modality PS 05-03
duchenne 106
durvalumab PS 18-03
dv1-k-(dv3) PS 22-05
dwi PS 02-01PS 04-05
dwi adc map PS 22-06
dynamic resting-state fmri PS 19-03
dysferlin PS 10-06
early stage PS 23-04
ecm characterization PS 23-03
eea1 PS 08-01
egcg modulation PS 23-03
egfr PS 18-05
elastic registration 106
electrical noise PS 22-03
electroencephalography (eeg) PS 09-03
electron tomography PS 23-05
electrophysiology PS 23-05
em-ultrastructure 106
embedding scaffold PS 04-04
emphysema PS 04-03
encapsulation 104
endbulb of held PS 23-05
endo-lysosomal system PS 08-01
endoscopy PS 18-04
endothelial cells PS 04-03
endothelial inflammation PS 23-03
endovascular thrombectomy PS 06-03PS 23-04
energetics #501
epidermal growth factor receptor PS 07-04PS 21-04PS 21-04
epilepsy PS 18-06
epileptogenesis PS 08-01PS 09-03
erdheim-chester disease PS 22-04
esophageal adenocarcinoma PS 05-02
euro-bioimaging eric PS 11-01
ex vivo lung micro-ct PS 04-03
ex vivo metabolism PS 21-02
ex-vivo PS 22-05
exchange PS 21-02
exendin PS 18-05
exosome 100
exosomes PS 18-02PS 18-05
extracellular lactate PS 06-03
extracellular matrix 105
extracellular matrix (ecm) PS 18-02
extracellular ph PS 22-04
extracellular ph/atp PS 13-01PS 18-02
extracellular vesicles PS 18-02PS 18-05100
fap PS 05-02
fapi-46 #293
fast field cyclimg PS 21-04
fast hepatic clearance 102
fatty acid metabolsim 100
fba PS 18-06
fdg PS 21-06100
fdg pet/cmr #518
fdg-pet 100
fe nanoparticles PS 22-05
feature stability PS 22-03
ferrocene derivatives PS 18-04
fes PS 18-05
fexi PS 21-02
fexsy PS 21-02
fibroblast 105
fibroblast activation protein (fap) #293
fibrosis PS 04-03PS 23-03100
fibrous dysplasia PS 09-02
field cancerization PS 04-05
field gradients PS 02-01
firefly xi PS 22-03
fixation 105
fixel-based analysis PS 18-06PS 23-04
fluorescence PS 18-04100104
fluorescence correlation spectroscopy PS 21-03
fluorescence guidance 120
fluorescence guided surgery PS 18-05
fluorescence guided-surgery #152
fluorescence imaging PS 04-04PS 05-02PS 18-04PS 18-05104120120
fluorescence lifetime imaging (flim) PS 08-03
fluorescence lifetime microscopy PS 10-06
fluorescence molecular imaging PS 05-02PS 07-04PS 07-04PS 18-03PS 21-04
fluorescence molecular tomography PS 22-03
fluorescence probe PS 21-03
fluorescence-guided surgery PS 21-04
fluorescence-mediated tomography PS 18-04
fluorescent 101
fluorescent guided surgery #239
fluorescent imaging 101
fluorescent molecular endoscopy PS 05-02
fluorescent molecular probes 105
fluorescent nanoprobe PS 21-03
fluorescent probes PS 08-03
fluorescent tracer PS 18-03
fluoresence molecular imaging PS 21-04
fluorinated compounds PS 21-02
fluorine PS 13-05PS 04-06102
fluorine-18 PS 08-02#98
fluorogenic biosensors PS 10-06
fluorophores PS 04-06
fmri PS 07-05PS 09-03PS 18-06PS 23-05PS 23-02
foam PS 23-03
folate PS 21-04
folic acid PS 18-05
fractal structure 102
fumarate PS 06-03
functional amyloid PS 21-03
functional connectivity PS 09-03PS 18-06
functional imaging PS 05-03PS 05-05
functional mri PS 09-03PS 18-06PS 19-01
functional ultrasound PS 05-03PS 10-06PS 19-01
functional ultrasound imaging PS 09-03
functional ultrasound imaging (fus) PS 09-03
functionalization 101
ga-68 #367
gadolinium 102102#533
gaers PS 18-06
galleria mellonella 100
gallium-68 PS 08-02
gamm PS 04-05
gastric emptying PS 21-06
gd based contrast agents PS 22-06
gemcitabine/abraxane PS 18-04
gene reporter imaging 104
gene therapy PS 06-02PS 19-02PS 17-05
gfp PS 21-03
glioblastoma PS 04-05PS 05-02PS 19-02PS 21-02PS 17-05
glioblastoma multiforme PS 09-02
glioma PS 04-05
glycolysis PS 09-02
glymphatic system PS 10-02
gold nanoparticles 105
gold nanorod PS 18-04101PS 17-05
gp96 PS 18-03
gvhd 100
hard-tissue PS 22-03
harmonic generation PS 08-03
harmonisation PS 22-03
hcc 100
hd PS 23-01
hd mouse model PS 23-04
head and neck cancer PS 07-04PS 08-02
head and neck squamouss cell carcinoma PS 21-04
heat stimulation PS 23-05
hemoglobin PS 22-05
heterogeneity PS 18-02
hibit PS 05-05
high-resolution 106
high-speed imaging PS 08-03
high-throughput drug screening PS 13-01
highly multiplexed microscopy PS 10-05
histology PS 04-04PS 22-03PS 17-01
homology PS 05-03
hsp90 PS 23-05
human brain PS 23-02
human tumor PS 15-03
human-sized scanner PS 10-04
huntingtin PS 15-05
huntington's disease PS 10-02PS 19-03PS 23-04PS 23-04PS 23-04
hyperpolarisation PS 21-06
hyperpolarization PS 02-01PS 19-03PS 21-06PS 21-02PS 21-02PS 21-02PS 21-02102PS 17-04PS 17-04
hyperpolarized PS 06-03
hyperpolarized 13c nmr PS 21-02
hyperpolarized 13c-mrsi PS 23-01PS 21-02
hyperpolarized [1-13c]pyruvate magnetic resonance spectroscopic imaging (mrsi) PS 09-02
hyperpolarized mr PS 21-06
hyperpolarized mri PS 14-02
hyperpolarized pyruvate PS 09-02
hyperpolarsied PS 08-04
hyperspectral imaging 105
hypometabolism. PS 23-04
hypoperfusion PS 23-04
hypoxia PS 04-05PS 04-04PS 18-05PS 19-02PS 17-05
icg emission maximum PS 22-05
icg fluorescence PS 22-05
iedda PS 05-03
il-6 PS 18-02
image analysis PS 23-03105
image guided drug delivery 101
image processing 106
image quality PS 23-02
image quality improvement. PS 22-03
image registration PS 10-02106PS 17-01
image regstration PS 22-03
image-derived input function PS 22-03
image-guided surgery 120
image-guided therapy 101
imaging PL 07-09-02PS 05-03PS 05-04PS 09-04PS 09-04105
imaging chamber PS 04-04
imaging flow cytometry PS 08-03
imaging metabolism PS 09-02
imaging of infection PS 05-04
imaging of intracellular ocygen PS 18-04
imaging technologies PS 11-01
imaging treatment responses PS 06-03
immune checkpoint imaging PS 18-03
immune checkpoint inhibitor PS 10-05
immune checkpoint molecule PS 10-05
immune evasion PS 01-01
immune suppression PS 13-01
immuno-pet PL 07-09-02
immunopet PS 05-04PS 10-05PS 18-01
immunotherapeutic drugs PL 07-09-02
immunotherapy PL 07-09-02PS 01-01PS 13-01PS 08-02PS 10-05PS 10-05PS 18-03PS 18-01
implants 120
imunopet #363
in ovo model PS 04-06
in vivo PS 10-06
in vivo dosimetry PS 22-06
in vivo fluorescence imaging PS 21-03
in vivo imaging PS 04-04
in vivo neuroimaging PS 23-02
in vivo tracking PS 18-05PS 18-05
in vivo validation PS 23-03PS 17-03
incision detection PS 21-04
indium-111 labelling PS 18-05
indocyanine green PS 21-04PS 22-05
infection PS 10-05
inflammation PS 16-02PS 16-02PS 05-04PS 10-03PS 19-03PS 23-04100100100100
inflammatory bowel disease PS 07-04
inflammatory cell stress 100
influenza PS 01-01
influenza-associated pulmonary aspergillosis PS 05-04
infrafrontier PS 11-01
innate immunity PS 16-02
integrative lung imaging 106
integrin avb3 PS 18-04
integrins PS 08-02PS 21-05
internalisation studies PS 22-06
intra-operative imaging PS 21-04
intracellular ph PS 21-03
intracellular signalling PS 01-01
intraoperative imaging PS 04-06PS 18-05PS 21-04
intraoperative mass spectrometry PS 17-01
intraperitoneal kainic acid rat model PS 18-06
intravenous PS 05-02
intravital microscopy PS 15-05PS 08-03105
intrinsic microscopy PS 07-05
inverse problems PS 10-04
iodine #533
ioluminescent PS 13-01
ion channel PS 22-04
ion channels PS 13-01PS 18-02PS 22-04
ion transport PS 13-01
ipf PS 23-03
irdye700 #239
iron oxide nanoparticles PS 22-06
ischemia PS 09-02PS 10-02PS 23-04
ischemic stroke PS 06-03PS 23-04PS 23-04
ivim-effect PS 18-05
jmrui PS 23-04
jr11 analogs PS 18-04
k+ channels PS 13-01PS 18-02
k-edge imaging PS 17-03
k2p2.1 channels PS 22-04
kidney PS 21-06106
kidney absorbed radiation dose PS 22-06
kidney disease PS 21-02
kit-based #367
krt81 PS 22-03
kurtosis PS 04-05
kynurenic acid PS 21-02
label-free 105
labeling PS 01-02#98
lanthanide PS 09-04
laparoscopic liver resection PS 21-04
laparoscopic surgery PS 21-04
large-scale brain networks PS 19-03
lesion symptom mapping PS 10-02
leucodystrophy PS 23-05
leukocyte 100
lidar 120
light sheet fluorescence microscopy PS 10-03104
light sheet microscopy PS 15-05PS 18-03105
light-induced antibody conjugation PS 04-06
light-sheet microscopy 105
lineage tracing PS 04-05
linear modelling PS 05-03
lipids PS 21-06
lipoproteins PS 22-05
liposome PS 10-03
liposomes 101
liquid biopsy PS 22-05
lithium treatment PS 23-02
lithium-7 (7li) PS 23-02
liver cirrhosis PS 22-05100
liver imaging PS 21-06
liver inflammation 100
longitudinal in vivo micro-computed tomography PS 23-03
longitudinal multiparametric mri 100
low count imaging PS 22-03
low density lipoproteins (ldl) PS 22-06
luciferase PS 15-05
luminescent reporters PS 09-04
lung PS 04-03PS 04-03100
lung biomarkers PS 23-03
lung function 106
lung imaging PS 10-06PS 23-03
lung tissue PS 23-03
lungs PS 04-03
lux PS 15-05
lymph node metastasis PS 07-04
lymphatic imaging #152
m2-like macrophages PS 18-03
machine learning PS 04-01PS 15-05PS 08-04PS 18-06PS 23-02
macrophage polarization PS 05-04
macrophages 100
magnetic fluid hyperthermia PS 08-02
magnetic hyperthermia PS 22-06
magnetic nanosystems PS 18-05
magnetic particle imaging PS 08-02PS 10-04102
magnetic resonance 100
magnetic resonance imaging PS 08-02PS 10-03PS 19-03PS 19-03PS 21-06PS 22-03104
magnetic resonance imaging (mri) PS 19-03PS 22-06PS 23-02
magnetic resonance spectroscopy PS 04-05
magnetic resonance spectroscopy (mrs) PS 23-02
magnetic targeting PS 18-05
major amputation 105
malate PS 06-03
maldi 105
maldi-msi PS 18-02
mammary carcinoma PS 18-03
mammary gland PS 04-05
mammary gland development PS 08-03105
mammary gland homeostasis PS 08-03105
mammary imaging window PS 08-03105
manganese complexes 104
margin assessment PS 21-04
marmoset model PS 23-03PS 17-03
mass spectrometry imaging PS 17-01PS 17-01
maternal immune stimulation PS 19-03PS 19-03
mcrpc PS 19-02PS 17-05
me-bssfp PS 21-06
mechanosensitive ion channels PS 22-04
medical imaging PS 04-01
melanoma PS 18-02PS 18-04
melt-electrowriting PS 10-04
membrane repair PS 10-06
memory PS 18-06PS 23-05PS 19-01
memri PS 18-06
meningioma PS 21-04
mesenchymal stem cells PS 19-02PS 17-05
metabolic PS 08-04
metabolic imaging PS 15-05PS 06-03PS 18-04PS 21-06PS 21-06
metabolic labelling 105
metabolic perturbation PS 06-03
metabolism PS 06-03PS 19-03PS 21-06PS 21-06PS 21-06PS 21-02PS 23-04PS 17-04PS 17-04
metal-enhance energy transfer PS 10-06
metal-organic framework PS 09-04
metals PS 08-03
metastasis PS 22-04
mettallomics PS 15-05
mhc class i presentation PS 10-05
mhtt PS 23-04
micelle core-labeling PS 19-02
micro-computed tomography PS 05-04
micro-computed tomography scanning PS 22-03
micro-ct PS 04-03106
microangioct PS 23-03
microcalcification PS 23-03
microcirculation 105
microcoil PS 21-02
microct PS 21-02PS 23-03PS 23-03#533106
microfluidics PS 15-03
microglia PS 10-02PS 19-03
microscopy PS 15-05PS 18-03PS 23-02105
microstructured optical fibre PS 05-03
middle cerebral artery occlusion PS 23-04
migration PS 06-03
mild tbi PS 23-03
milk exosomes PS 18-05
minflux PS 04-02
mitochondrial dynamics 100
mitochondrial oxidation PS 09-02
mn(ii)-based t1 contrast 102
model-based reconstruction PS 10-04PS 21-06PS 22-03
modelling PS 18-04
molecular fluorescence-guided surgery 105
molecular imaging PS 15-05PS 05-05PS 18-03PS 18-04
molecular mr and us PS 23-03
molecular subtyping PS 22-03
mongolian gerbil PS 23-05
monoclonal antibody PS 18-04
monocytes PS 21-02
morphological sv pools PS 23-05
motor cortex PS 09-03
mouse PS 10-02
mouse atlas 120
mouse models PS 10-02
mouse pulmonary vasculature PS 04-03
mpi PS 10-04102
mpo 100
mr PS 21-06
mr angiography PS 23-04
mr contrast agent 102
mr spectra PS 23-04
mr spectroscopy PS 21-02
mr-based agents PS 14-02
mri PS 01-02PS 02-01PS 02-01PS 04-01PS 13-05PS 06-02PS 08-04PS 09-02PS 10-04PS 10-02PS 18-06PS 19-03PS 19-03PS 21-02PS 21-02PS 21-02PS 22-05PS 23-02100101102104
mri contrast agents 101
mri hardware PS 02-01
mri magnet design PS 02-01
mri sensors PS 23-01
mri spectroscopy PS 21-06PS 17-04
mrs PS 02-01#501PS 21-02100
msi 105
msmt-csd PS 23-04
msot PS 05-05PS 09-02PS 22-03
mt PS 02-01
multi modal brain mri PS 18-06
multi pinhole spect PS 22-03
multi-color luciferase PS 13-01
multi-gradient-echo PS 21-06
multi-modal registration PS 04-04
multimers PS 21-05
multimodal imaging PS 08-01PS 08-01PS 04-04105
multimodal microscopy PS 13-06
multimodal preclinical imaging-supported mouse model PS 05-04
multimodality PS 04-06104
multiparametric mri PS 08-02PS 22-03
multiphoton PS 13-06
multiphoton 3d reconstruction PS 10-05PS 18-01
multiple sclerosis PS 18-06
multiple myeloma PS 10-03
multiplexing PS 18-03
multiscale imaging PS 16-02104
multispectral analysis 105
multispectral optoacoustic tomography PS 22-05
muscle physiology PS 09-02
myocardial perfusion PS 22-03
myoferlin PS 10-06
myositis 100
n-(4-[18f]fluorophenyl)maleimide PS 21-05
nanobit system PS 05-05
nanobodies PS 06-02PS 10-03PS 21-03PS 23-03
nanoluc luciferase PS 05-05
nanomaterial PS 21-03
nanomaterials PS 21-03
nanomedicine PS 10-03PS 22-05
nanoparticle PS 01-02100
nanoparticles PS 08-02PS 18-05PS 21-02100101104
nanoprobe PS 21-04
nanoscopy PS 04-02PS 08-03
nanovaccine PS 18-03
nanowires PS 06-02
nash 100
near infrared 105
near-infrared PS 09-04PS 09-04
near-infrared fluorescence PS 21-03
near-infrared fluorescence imaging PS 21-04
near-infrared luminescence PS 10-05
nearest neighbor distance analysis PS 08-04
necrosis PS 06-03
necrosis imaging PS 06-03
necrosis-avidity 105
neonates PS 05-03
nets PS 18-04
neural activity PS 07-05
neural circuits PS 09-03
neurodegeneration PS 15-05
neuroendocrine neoplasms PS 07-04
neuroimaging PS 07-05PS 05-03PS 19-03PS 19-03PS 19-03PS 23-02#437
neuroinfection PS 23-04
neuroinflammation PS 09-03PS 10-02PS 19-03PS 19-03
neurology PS 22-03
neuromuscular diseases PS 05-05
neuronal reconnecting PS 18-06
neuronavigation PS 10-06PS 19-01
neurons PS 08-03
neuroreceptor PS 18-06
neurovascular coupling PS 09-03
neutral sphingomyelinase PS 18-06
nhs chemistry PS 21-03
nir dyes PS 21-04
nir imaging PS 04-06
nir-ii imaging PS 18-05PS 22-05
nitrioxide free radicals PS 21-02
nmr PS 02-01
nmr relaxometry PS 21-04
no-reflow phenomenon PS 23-04
non-alcoholic steatohepatitis 100
non-invasive imaging PS 01-01
non-invasive monitoring PS 01-01
norepinephrine PS 18-06
normal tissue distribution PS 18-05
novel biomarkers PS 05-02
nsclc PS 18-05
nuclear imaging PS 04-05
numerical modeling PS 21-02
obesity PS 21-06PS 17-04
odnp PS 21-02
ogtt PS 21-06
omega-3 PS 19-03
oncogenic viruses PS 01-01
oncology PS 10-05PS 10-03PS 22-05
oncolytic virotherapy PS 10-05PS 18-01
oncolytic viruses PS 01-01
open access PS 11-01
open science PS 09-03
optical PS 23-03
optical cochlear implant PS 15-05
optical imaging PS 18-02PS 18-05PS 18-05PS 21-04PS 22-05100104
optical probes PS 09-04
optical projection tomography PS 04-03
optimisation #98
optoacoustic imaging PS 05-05
optoacoustic tomography PS 05-03
optoacoustic/photoacoustic tomography PS 05-05
optoacoustics PS 13-06PS 05-05PS 22-05120
optofluidics PS 05-03
optogenetic hearing restoration PS 15-05
optogenetics PS 09-03
oral cancer detection PS 05-02
organic dye PS 18-05
organoid PS 13-01
organoids PS 18-03
organophosphate PS 19-03
oseltamivir PS 05-04
ovarian PS 21-04
ovarian cancer PS 18-02
overhauser 102PS 17-04
oxine #367
oxygen PS 04-04
oxygen metabolism PS 10-02
p2x7r PS 18-02
paclitaxel PS 22-06
pan-cancer PS 18-02
pancreas PS 18-02
pancreatic cancer PS 13-01PS 13-01PS 18-03PS 18-05
pancreatic ductal adenocarcinoma PS 13-01PS 13-01PS 04-05PS 18-02PS 22-04101
pancreatic ductal adenocarcinoma cancer PS 18-02
para-hydrogen PS 21-02PS 17-04
paracest PS 06-03102
paragangliomas PS 22-03
parahydrogen PS 21-02
parp inhibitors PS 05-02
parp1 PS 18-02PS 19-02
parp1 imaging PS 05-02
parpi PS 19-02
partial volume correction PS 22-03
particle imaging PS 06-02
particle tracking PS 06-02
pathology PS 22-03
patient derived organoids PS 13-01
patient stratification PS 10-03
pckd 106
pd-l1 PS 10-05
pdac PS 09-02PS 18-02PS 18-02PS 18-03PS 18-03PS 18-04PS 22-03PS 22-04PS 22-04PS 22-04PS 22-06
pdgrb PS 23-03
pdt PS 19-02
pearson correlation. PS 22-03
pediatrics PS 05-05
peptide ligand PS 18-05
peptide receptor radionuclide therapy (prrt) PS 07-04
peptides PS 21-05
peptobrush PS 23-02
perfluorocarbon PS 10-03
perfluorocarbons 102
perfusion PS 23-03
perfusion mri PS 10-04
perfusion pet-mri PS 23-04
permeability PS 21-02PS 21-02
personalised medicine PS 13-01
personalized medicine PS 15-05
pet PS 01-02PS 04-01PS 15-05PS 04-04PS 04-03PS 05-04PS 06-02PS 08-04PS 08-02PS 08-02PS 09-03PS 18-05PS 19-03PS 19-03PS 19-03PS 19-03PS 19-02PS 21-05PS 22-03PS 22-03PS 22-05PS 23-02PS 23-04104PS 17-05
pet cell tracking #367
pet imaging PS 01-02PS 04-03PS 05-02PS 18-05PS 19-03PS 23-04
pet mpi PS 22-03
pet registered ultrafast sonography PS 22-03
pet tracer PS 04-06
pet tracer development #437
pet-ct 100
pet-imaging PS 07-04
pet-mri PS 06-03100
pet/ct PS 05-04PS 18-05PS 22-03100
pet/mri #322PS 10-04PS 10-02
pet/mri imaging PS 18-05
ph PS 13-01PS 18-02PS 21-02PS 22-04
ph imaging PS 23-01
ph-imaging PS 21-06
phagocytes 100PS 18-01
pharmacokinetics PS 21-05
phase contrast PS 04-04#338PS 23-03
phase-change contrast agents PS 22-06
phase-contrast 106
phase-contrast imaging PS 10-06
phase-contrast tomography 106
phosphatidylinositol phosphates PS 08-04
phosphorus-based polymer 102
photo-cidnp PS 21-02
photo-cleavable PS 09-04
photoacousics PS 05-03
photoacoustic PS 08-04PS 22-03PS 23-03
photoacoustic imaging PS 04-06104
photoacoustics PS 09-02PS 21-06
photodynamic therapy #239PS 21-04PS 21-04
photon-counting PS 17-03
photon-counting technology 106
photothermal therapy PS 18-04101101PS 17-05
photothermia PS 22-06
physico-chemical paramters PS 01-02
pib PS 19-03
plastics 120
plga nanoparticles 120
plga-nh2 nanoparticles PS 18-05PS 18-05
pneumonia PS 01-01
polycaprolactone PS 10-04
polyelectrolyte microcapsules PS 18-04101
polyelectrolyte/magnetite capsules PS 18-05
polymeric micelles PS 19-02
polymeric nanoparticle PS 07-04
polymersomes 104
polypyrrole 104
positron emission tomography PS 06-02PS 08-02PS 18-06PS 23-03101104PS 17-05
positron emission tomography. PS 18-04
positron-emission-tomography PS 23-05
preclinical PS 23-01PS 18-06PS 21-02
preclinical imaging PS 08-01PS 21-06
preclinical model PS 22-04PS 23-04
preclinical mri PS 10-02
preclinical research PS 23-03
press 1h PS 21-06
pressure PS 22-04
pretargeted imaging PS 08-02PS 21-05
pretargeting PS 08-02PS 23-02
probe PS 01-02
programmed death ligand 1 PS 10-05PS 18-01
proliferative heterogeneity PS 08-03105
prostate cancer PS 04-06#239PS 07-04PS 18-02PS 19-02PS 21-04PS 21-04PS 22-06
protacs PS 10-05
protein turnover 105
protein-protein interactions PS 09-04
proteins PS 01-02
proteoglycans PS 04-05
proteomic profile PS 18-02
protoporphyrin ix PS 18-04
psf reconstruction PS 22-03
psma PS 04-06#239PS 07-04PS 19-02PS 19-02PS 21-04PS 21-04PS 22-06PS 22-06104PS 17-05
psma-617 PS 22-06
psychiatric disorders PS 19-03
pulmonary blood vessels PS 04-03
purinergic receptors PS 13-01PS 18-02
pyruvate PS 21-02PS 21-02PS 17-04
quality control PS 22-03
quantification PS 08-04PS 22-03
quantification of fluorescence PS 22-03
quantum dots PS 18-04
quasi-periodic patterns PS 19-03
rab5 PS 08-01
rab7 PS 08-01
radial mri PS 21-06PS 23-03
radicals 102PS 17-04
radio diagnostics PS 21-05
radio-guided surgery PS 07-04
radio-sensitization PS 10-05PS 18-01
radioactivity PS 10-03PS 18-05
radiochemistry PS 01-02PS 04-01PS 05-04
radioiodination PS 21-05
radioiodine PS 19-02
radiolysis #363
radiometals PS 21-05
radiomics PS 04-01PS 22-03100
radionuclide imaging #433
radionuclide therapy PS 18-04PS 22-06
radiosensitization PS 19-02
radiotheranostics PS 19-02
radiotherapy PS 22-06
radiotracer PS 06-02PS 23-02
radiotracer design PS 01-02
radiotracers PS 01-02
raman-microscopy PS 04-06
rapid-eye-movement sleep (rems) PS 09-03
rare disease PS 05-05
rat PS 09-03PS 23-03
rat model PS 19-03
real time imaging PS 18-04
reconstruction PS 23-02
reconstruction algorithm PS 22-03
reconstruction algorithms PS 22-03
rectal cancer PS 18-04
redox sensor 100
redox-responsive probe 102
registration PS 21-04
relaxometry PS 10-04
remodeling PS 10-06
repeated measurements PS 23-05
repeated social defeat PS 19-03
repopulation PS 10-02
reporter gene PS 05-05PS 18-05
reporter gene imaging PS 01-01
reporter genes PS 01-02
reportergene PS 06-02
reporters 120
resolution 105
resorufin PS 23-02
resting state PS 18-06PS 23-05
resting state functional mri PS 10-02
resting-state fmri PS 23-04
retention 102
retina PS 23-04105106
retinal ischemia PS 23-04
rf coils PS 02-01
rhodamine isomers PS 08-03PS 09-04
riboflavin 5’-monophosphate sodium salt hydrate PS 21-02
rlt PS 19-02PS 19-02PS 17-05
rnai screen PS 13-01
rodent PS 05-03PS 09-03
ros PS 18-02
ros detection PS 04-06
rucaparib PS 19-02
s1 PS 23-05
sabre PS 21-02
sars-cov-2 PS 01-01PS 05-04100
scaffold remodelling PS 23-03
schizophrenia PS 19-03PS 19-03PS 19-03
secondary ion mass spectrometry 105
self-gating PS 23-03
sensitivity 105
sensory cortex PS 23-05
shg 105
shg imaging PS 23-03PS 17-03
short wave infrared imaging #152
short-wave infrared (swir) PS 08-03
shortwave infrared PS 04-04
silica nanoparticles 104
silica particles PS 06-02
simultaneous pet/mri 100100PS 18-01
single-cell imaging PS 18-03
single-domain antibodies PS 21-03
single-molecule loclization microscopy PS 10-06
single-vessel fmri PS 05-03
small animal PS 22-03
small animal fmri PS 22-03
small animal pet/ct PS 05-02
small molecule PS 18-05
small molecules PS 01-02
small radioligands PS 05-02
smlm PS 09-04
snaptag PS 06-02
sodium imaging PS 21-02
sodium iodide symporter #433PS 19-02PS 17-05
soft-tissue sarcoma #293
somatostatin receptor subtype 2 105
spad 120
spatial coherence PS 05-05
specific targeting PS 22-06
spect #433PS 22-05PS 23-05
spect imaging PS 18-03
spect iq phantom PS 22-03
spect/ct 105
spect/ct imaging PS 18-05
spectral ct PS 17-03
spectral imaging PS 04-04PS 08-04100
spectroscopy #501PS 21-06PS 21-02
spinal cord injury PS 05-04
spinal cord lesion PS 18-06
spion 102
spions 101
spleen 102
split fluorescent reporters PS 09-04
spondyloarthritis PS 22-05
sstr antagonist PS 07-04
sstr2 PS 18-04PS 21-04
stack-of-stars PS 10-04
stat3 PS 18-02
sted PS 09-04
sted microscopy PS 08-03PS 09-04
stem cell therapy 105
stem cells PS 08-03
stroke PS 08-04PS 09-02PS 10-02PS 19-03
structural brain connectivity PS 18-06
structural imaging PS 22-06
super-resolution PS 15-03PS 05-05PS 09-04PS 23-02
super-resolution microscopy PS 08-04
superparamagnetic iron oxide nanoparticles 102
superresolution PS 04-02
surface modification 104
surgical microscope PS 21-04
sv2a PS 09-03
swir PS 22-03120
synapse PS 15-03
synapse density PS 09-03
synaptic density PS 18-06
synchrotron 106
synchrotron x-ray fluorescence imaging PS 08-03
synchrotrons PS 04-03
t cells PS 10-03
t-cell infiltration PS 18-03
t-cell lymphoma PS 21-06
t-ceus PS 23-02
t1 PS 02-01
t1-map PS 22-06
t2 PS 02-01
t2-map PS 22-06
target expression PS 18-04
target registration error PS 21-04
targeted drug delivery PS 18-04
targeted radiotherapy PS 21-05
targeted therapies PS 18-04
tdcs PS 21-02
temporal lobe epilepsy PS 18-06
test criteria PS 01-02
test-sample 120
testis 105
tetrahidrocannabinol PS 19-03
tetrazine PS 23-02
tetrazine ligation PS 06-02
tetrazines PS 08-02PS 08-02PS 21-05#98
texture analysis PS 22-03
texture features #518
tga PS 23-02
theranostic PS 04-06PS 22-06
theranostics PS 01-02PS 05-02PS 10-03101101
therapy PS 23-01
thermal decomposition 102
thg 105
threshold PS 22-03
thrombi PS 23-03
thyroid cancer PS 22-05
thyroid nodule PS 22-05
tilmanocept PS 18-03
time-gated delayed fluorescence PS 18-04
time-lapse mri PS 21-02
time-of-flight 120
tirf imaging PS 21-03
tissue characterization PS 05-05105
tissue clearing 100
tissue immunofluorescence PS 10-05PS 18-01
tissue microenvironment PS 15-05
tissue staining PS 08-03
toc PS 21-04
tocilizumab PS 18-02
toll-like receptors PS 23-04
tomographic imaging PS 10-04
tomography PS 04-04PS 18-05PS 23-03
tools PS 08-04
tpef PS 23-03PS 17-03
tracer development PS 04-01
trackable delivery PS 18-04
trail PS 22-04PS 22-04
trans-cyclooctene PS 06-02
transcriptomics PS 05-03
transferrin receptor PS 23-02PS 23-02
transfontanellar contrast-enhanced ultrasound PS 23-02
transgenic mice PS 13-01
transgenic mouse PS 22-05
transgenic mouse models PS 19-03
translation PS 05-03
translational microscopy PS 13-06
translocator protein PS 09-03
transposition of great arteries PS 23-02
traumatic brain injury PS 19-03
trifluoromethylation PS 21-05
trimetallic nanocomposites 104
tspo PS 04-05PS 19-03
tumor acidosis PS 21-06
tumor associated macrophages PS 13-01
tumor heterogeneity PS 22-03
tumor imaging #152PS 22-05
tumor immunology PS 15-05#572
tumor invasiveness PS 04-05
tumor margin PS 21-04
tumor microenvironment PL 07-09-02PS 01-01#572PS 09-02PS 10-05PS 18-02PS 18-03PS 18-03PS 18-05PS 22-03101PS 17-05
tumor vasculature imaging #152
tumor-associated macrophages PS 10-03
tumour immunology PS 01-01
tumour microenvironment PS 22-04
tumour theranostics PS 18-05
two-photon microscopy PS 08-03
uct PS 23-03
ulcerative colitis PS 07-04
ulf mri PS 21-02
ultrafast ultrasound imaging #551PS 22-03
ultrashort te PS 21-06
ultrasmall superparamagnetic iron oxide PS 10-04
ultrasonic imaging PS 05-05
ultrasound PS 10-06PS 22-06PS 23-02101101102PS 19-01
ultrasound localisation microscopy #551
ultrasound probe calibration PS 21-04
unmixing 120
unsupervised image classification PS 22-03
unsupervised unmixing PS 08-04
uspios PS 10-04
ute #501PS 23-03
vaccines PS 01-01
validation PS 09-03
vascular amyloid PS 23-02
vascular brain activity PS 09-03
vascular imaging PS 10-04PS 23-02PS 23-03PS 23-03
vascular inflammation PS 05-04
vascular labeling PS 04-03
vascular promotion 101PS 17-05
vedolizumab PS 07-04
vegf-a PS 05-02
vesicle PS 15-03
virotherpay PS 01-01
virtual histology PS 04-04PS 23-03106106
vis/nir/swir PS 09-04
volumetric imaging PS 23-02
water/fat separation PS 21-06
whole-body imaging PS 05-05
x-ray PS 04-04#338PS 10-06PS 18-05106
x-ray fluorescence PS 21-02
x-ray imaging 106
x-ray microtromography PS 04-03
x-ray phase-contrast PS 04-04
x-ray phase-contrast tomography PS 08-04
x-ray tomography PS 23-03106
xenograft model PS 18-05
xfct PS 21-02
xrf PS 21-02
z-ompd PS 23-01
zebrafish PS 04-04
zirconium-89 PS 04-06#363
zirconium-89 labelling PS 18-05
zn2+ imaging PS 23-01
zr-89 #367
zymonic acid PS 21-02
µct PS 23-03
µct system 106
α-therapy PS 19-02
β-enac-tg PS 04-03